Vanguard Group Inc Castle Biosciences Inc Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,047,565 shares of CSTL stock, worth $32.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,047,565
Previous 1,832,535 11.73%
Holding current value
$32.7 Million
Previous $48.8 Million 16.06%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$18.76 - $32.72 $4.03 Million - $7.04 Million
215,030 Added 11.73%
2,047,565 $41 Million
Q4 2024

Feb 11, 2025
BUY
$26.52 - $34.67 $2.22 Million - $2.9 Million
83,783 Added 4.79%
1,832,535 $48.8 Million
Q3 2024

Nov 13, 2024
BUY
$17.4 - $31.47 $2.98 Million - $5.39 Million
171,238 Added 10.85%
1,748,752 $49.9 Million
Q2 2024

Aug 13, 2024
BUY
$18.84 - $24.94 $1.57 Million - $2.08 Million
83,338 Added 5.58%
1,577,514 $34.3 Million
Q1 2024

May 10, 2024
BUY
$18.06 - $25.3 $590,471 - $827,183
32,695 Added 2.24%
1,494,176 $33.1 Million
Q4 2023

Feb 14, 2024
BUY
$12.19 - $22.43 $269,313 - $495,545
22,093 Added 1.53%
1,461,481 $31.5 Million
Q3 2023

Nov 14, 2023
BUY
$13.28 - $20.3 $158,921 - $242,930
11,967 Added 0.84%
1,439,388 $24.3 Million
Q2 2023

Aug 14, 2023
BUY
$11.66 - $26.0 $274,243 - $611,520
23,520 Added 1.68%
1,427,421 $19.6 Million
Q1 2023

May 15, 2023
BUY
$19.47 - $28.49 $217,616 - $318,432
11,177 Added 0.8%
1,403,901 $31.9 Million
Q4 2022

Feb 10, 2023
BUY
$18.08 - $30.0 $2.57 Million - $4.26 Million
141,991 Added 11.35%
1,392,724 $32.8 Million
Q3 2022

Nov 14, 2022
BUY
$22.51 - $34.32 $898,981 - $1.37 Million
39,937 Added 3.3%
1,250,733 $32.6 Million
Q2 2022

Aug 12, 2022
BUY
$16.0 - $45.99 $553,104 - $1.59 Million
34,569 Added 2.94%
1,210,796 $26.6 Million
Q1 2022

May 13, 2022
BUY
$33.17 - $46.98 $444,013 - $628,874
13,386 Added 1.15%
1,176,227 $52.8 Million
Q4 2021

Feb 14, 2022
SELL
$39.06 - $67.58 $130,733 - $226,190
-3,347 Reduced 0.29%
1,162,841 $49.9 Million
Q3 2021

Nov 12, 2021
BUY
$60.13 - $77.6 $2.34 Million - $3.03 Million
38,996 Added 3.46%
1,166,188 $77.6 Million
Q2 2021

Aug 13, 2021
BUY
$50.07 - $76.78 $56.4 Million - $86.5 Million
1,127,192 New
1,127,192 $82.7 Million

Others Institutions Holding CSTL

# of Institutions
192
Shares Held
26.7M
Call Options Held
9.5K
Put Options Held
5K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $420M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email